Great. Thanks, Shai. I'll review highlights of our Q3 results and provide our expectations for Q4 and the full year and then we'll take some questions. Overall, it was again a terrific quarter with results very much in line with or better than expectations and continued notable loss ratio improvement across the board. In-force premium grew 24% to $889 million while customer count increased by 17% to $2.3 million. Premium per customer increased 6% versus the prior year to $384, driven primarily by rate increases. Annual dollar retention or ADR was 87%, up 2 percentage points since this time last year and down slightly versus 88% in the prior quarter. This slight sequential decline is as expected given our efforts to reduce less profitable portions of our home book. In the second half of this year, gross earned premium in Q3 increased 23% as compared to the prior year to $213 million in line with IFP growth. Revenue in Q3 increased 19% from the prior year to $137 million. This growth in revenue was driven primarily by the increase in gross earned premium, a slightly higher effective ceding commission rate under our quota share reinsurance and a 27% increase in investment income. Our gross loss ratio was 73% for Q3 as compared to 83% in Q3 2023 and 79% in Q2 this year. Excluding the total impact of CATs in Q3, which was roughly 5 percentage points, our gross loss ratio ex-CAT was 68%. CAT impact in the quarter was driven primarily by named storms and hurricanes and was about 5 points better than the prior year and 12 points better sequentially. Total prior period development had a roughly 3% favorable impact, about 1% of that from CAT and about 2% non-CAT. Trailing 12 months or TTM loss ratio was about 77% or 11 points better year-on-year and 2 points better sequentially. All of these insurance metrics and more are included in our new insurance supplement that you'll find at the end of our shareholder letter this quarter and going forward. Gross profit increased 71% as compared to the prior year driven primarily by premium growth and significant loss ratio improvement, while adjusted gross profit increased 55% driven by premium growth and loss ratio improvement. Operating expenses excluding loss and loss adjustment expense increased 27% to $125 million in Q3 as compared to the prior year. The increase of $26 million year-on-year was driven predominantly by an increase in growth acquisition spending within sales and marketing of approximately $27 million, offset by fixed cost savings. Absent the growth spend increase, operating expenses were roughly unchanged year-on-year. Other Insurance expense grew 31% in Q3 versus the prior year, slightly ahead of the growth of earned premium. Total sales and marketing expense, as noted, increased by $27 million primarily due to increased growth spent, partially offset by lower personnel related costs driven by efficiency gains. Total growth spent in the quarter was $40 million, roughly triple the $13 million in the prior year. We continue to utilize our synthetic agent’s growth funding program and have financed 80% of our growth spend since the start of the year. As a reminder, you'll see 100% of our growth spend flow through the P&L as always. While the impact of the synthetic agent’s mechanism is visible on the cash flow statement and the balance sheet and the net financing to date is about $67 million as of September 30th. Technology development expense was flat year-on-year at $22 million due primarily to continuing cost efficiencies. G&A expense declined 15% as compared to the prior year to $31 million primarily due to lower personnel and insurance expenses and one time impacts in both quarters. Absent these non-recurring impacts, the G&A decline was somewhat less but still meaningful at approximately 7% better. Personnel expense and headcount control continue to be a high priority. Total headcount is down about 7% as compared to the prior year at 1216, while the top line IFP again grew fully 24% including outsourced personnel expense which has been part of our strategy for several years this expense improvement rate is similar. Our net loss was a loss of $68 million in Q3 or $0.95 per share, a 10% decline as compared to the third quarter of 2023 and this change again driven primarily by our increased growth spend. Our adjusted EBITDA loss was $49 million in Q3 versus $40 million in the prior year. Our total cash, cash equivalents and investments ended the quarter up significantly at approximately $979 million, up $48 million versus the prior quarter, showing a continuing positive net cash flow trend. With these metrics in mind, I'll outline our specific financial expectations for the fourth quarter and the full year. We are increasing our full year expectations for both revenue and gross earned premium, while our other guidance metrics remain unchanged as compared to our prior guidance. As has been the case in some prior years, there is a notable seasonal difference in our expected results in Q3 versus Q4. Specifically, Q3 is typically our highest growth spend quarter of the year, which drives up sales and marketing spend and also typically a higher expected loss ratio as compared to Q4. Our loss ratio experience, especially for CAT in the third quarter this year was quite favorable as compared to our expectations and this drove over performance in Q3, which doesn't necessarily recur in Q4. Our fourth quarter guidance therefore incorporates our typical view for expected results. From a gross spend perspective we expect to invest roughly $35 million in Q4, which is nearly three times the growth spend from Q4 in the prior year, to generate profitable customers with a healthy lifetime value. We noted last quarter that we also expected to remove approximately $25 million of homeowners IFP or enforced premium from our book, excuse me, in the second half of 2024, roughly 2/3 of that in Q3, and this effort serves to somewhat dampen growth in the immediate term while concurrently boosting cash flow and profitability in the medium term, and further reducing CAT volatility and we are on track with those prior estimates. Importantly, though our IFP guidance for the year reflects these plans, it also remains unchanged. We expect that additional growth and marketing efficiencies will continue to offset the impact of these non-renewals. For the fourth quarter of 2024, we expect in-force premium at December 31st between $940 million and $944 million. Gross earned premium of $222 million to $225 million, revenue of $144 million to $146 million, an adjusted EBITDA loss of between $29 million and $25 million, stock based compensation expense of approximately $16 million, capital expenditures of approximately $3 million and a weighted average share count for the quarter of approximately 72 million shares. And for the full year 2024, we expect again enforced premium at the end of the year of $940 to $944, gross earned premium of between $823 million and $826 million, revenue between $522 million and $524 million, adjusted EBITDA loss between $155 million and $151 million, stock based compensation expense of approximately $64 million, capital expenditures of approximately $10 million and a weighted average share count of approximately 71 million shares for the full year. And with that I would like to hand things back over to Shai to answer some questions from our retail investors.